{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:00:28Z","timestamp":1773309628486,"version":"3.50.1"},"reference-count":14,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2019,9,27]]},"DOI":"10.1536\/ihj.19-116","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T18:08:36Z","timestamp":1567534116000},"page":"1222-1225","source":"Crossref","is-referenced-by-count":8,"title":["Cilostazol Is Useful for the Treatment of Sinus Bradycardia and Associated Hemodynamic Deterioration Following Heart Transplantation"],"prefix":"10.1536","volume":"60","author":[{"given":"Tomoki","family":"Uchikawa","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Fujino","sequence":"additional","affiliation":[{"name":"Department of Advanced Cardiopulmonary Failure, Faculty of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiki","family":"Higo","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kisho","family":"Ohtani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shiose","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Faculty of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tsutsui","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ponikowski P, Voors AA, Anker SD, <i>et al<\/i>. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-200.","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Melton IC, Gilligan DM, Wood MA, <i>et al<\/i>. Optimal cardiac pacing after heart transplantation. Pacing Clin Electrophysiol 1999; 22: 1510-27.","DOI":"10.1111\/j.1540-8159.1999.tb00356.x"},{"key":"3","unstructured":"3. Miyamoto Y, Curtiss EI, Kormos RL, <i>et al<\/i>. Bradyarrhythmia after heart transplantation. Incidence, time course, and outcome. Circulation 1990; 82: IV313-7."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Heinz G, Hirschl M, Buxbaum P, <i>et al<\/i>. Sinus node dysfunction after orthotopic cardiac transplantation: postoperative incidence and long-term implications. Pacing Clin Electrophysiol 1992; 15: 731-7.","DOI":"10.1111\/j.1540-8159.1992.tb06838.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jones DG, Mortsell DH, Rajaruthnam D, <i>et al<\/i>. Permanent pacemaker implantation early and late after heart transplantation: clinical indication, risk factors and prognostic implications. J Heart Lung Transplant 2011; 30: 1257-65.","DOI":"10.1016\/j.healun.2011.05.010"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Costanzo MR, Dipchand A, Starling R, <i>et al<\/i>. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010; 29: 914-56.","DOI":"10.1016\/j.healun.2010.05.034"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bertolet BD, Eagle DA, Conti JB, <i>et al<\/i>. Bradycardia after heart transplantation: reversal with theophylline. J Am Coll Cardiol 1996; 28: 396-9.","DOI":"10.1016\/0735-1097(96)00162-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Perez P, Esteban C, Sauquillo JC, <i>et al<\/i>. Cilostazol and outcome in outpatients with peripheral artery disease. Thromb Res 2014; 134: 331-5.","DOI":"10.1016\/j.thromres.2014.05.040"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Huang Y, Cheng Y, Wu J, <i>et al<\/i>. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. Lancet Neurol 2008; 7: 494-9.","DOI":"10.1016\/S1474-4422(08)70094-2"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shinohara Y, Katayama Y, Uchiyama S, <i>et al<\/i>. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol 2010; 9: 959-68.","DOI":"10.1016\/S1474-4422(10)70198-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kodera S, Kiyosue A, Ando J, <i>et al<\/i>. Cost-effectiveness analysis of cardiovascular eisease treatment in Japan. Int Heart J 2017; 58: 847-52.","DOI":"10.1536\/ihj.17-365"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kwon BJ, Lee SH, Kim DB, <i>et al<\/i>. A randomized comparison study assessing the impact of cilostazol on the heart rate and arrhythmias by 24-hour ambulatory holter electrocardiographic monitoring after drug-eluting stent implantation for coronary artery disease. J Atheroscler Thromb 2015; 22: 152-64.","DOI":"10.5551\/jat.25577"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Atarashi H, Endoh Y, Saitoh H, <i>et al<\/i>. Chronotropic effects of cilostazol, a new antithrombotic agent, in patients with bradyarrhythmias. J Cardiovasc Pharmacol 1998; 31: 534-9.","DOI":"10.1097\/00005344-199804000-00010"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Rogers KC, Oliphant CS, Finks SW. Clinical efficacy and safety of cilostazol: a critical review of the literature. Drugs 2015; 75: 377-95.","DOI":"10.1007\/s40265-015-0364-3"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/5\/60_19-116\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T00:04:04Z","timestamp":1569629044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/5\/60_19-116\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.19-116","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,27]]}}}